Cholestyramine
NDC 27241-134, Cholestyramine, powder, for suspension, from Ajanta Pharma USA Inc..
- Product NDC
- 27241-134
- Status
- Listed
- Labeler
- Ajanta Pharma USA Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211119
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27241-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/9g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27241-134-36 | 27241013436 | 60 PACKET in 1 CARTON (27241-134-36) / 9 g in 1 PACKET (27241-134-21) |
| 27241-134-51 | 27241013451 | 378 g in 1 BOTTLE (27241-134-51) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a0b64dfe-49bc-45d7-9281-9e9d6e296c40NADAC price for package 27241013436
GET /v1/drugs/nadac/27241013436NADAC price for package 27241013451
GET /v1/drugs/nadac/27241013451
Use it
Look up 27241-134 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27241-134 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27241-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.